1-6 of 6
Lynne A. Bui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Clinical Activity in a Phase I Trial of the BCR-ABL/IGF- 1R/Aurora Kinase Inhibitor XL228 in Patients with Ph + + Leukemias with Either Failure to Multiple TKI Therapies or with T315I Mutation

Free
Jorge Cortes, MD, Ronald Paquette, MD, Moshe Talpaz, Javier Pinilla, MD, PhD, Ekatherine Asatiani, MD, Meir Wetzler, MD, Jeffrey H. Lipton, MD, PhD, Corynn Kasap, BS, Lynne A. Bui, MD, Douglas O. Clary, PhD, Neil Shah, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3232.
https://doi.org/10.1182/blood.V112.11.3232.3232
Published: 2008
Journal Articles

A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Polycythemia Vera

Free
Ronald Paquette, MD, Lubomir Sokol, MD, PhD, Neil P. Shah, MD, PhD, Richard T. Silver, MD, Alan F. List, MD, Douglas O. Clary, Lynne A. Bui, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2008) 112 (11): 2810.
https://doi.org/10.1182/blood.V112.11.2810.2810
Published: 2008
Journal Articles

A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Free
Neil P. Shah, MD, PhD, Patrycja Olszynski, Lubomir Sokol, MD, PhD, Srdan Verstovsek, Ronald Hoffman, MD, Alan F. List, MD, Jorge Cortes, MD, Hagop M Kantarjian, D. Gary Gilliland, Douglas O Clary, PhD, Lynne A. Bui, MD, Martha Wadleigh, MD
Journal: Blood
Blood (2008) 112 (11): 98.
https://doi.org/10.1182/blood.V112.11.98.98
Published: 2008
Journal Articles

Targeting Drug-Resistant CML and Ph+-ALL with the Spectrum Selective Protein Kinase Inhibitor XL228.

Free
Neil P. Shah, Corynn Kasap, Ronald Paquette, Jorge Cortes, Javier Pinilla, Moshe Talpaz, Lynne A. Bui, Douglas O. Clary
Journal: Blood
Blood (2007) 110 (11): 474.
https://doi.org/10.1182/blood.V110.11.474.474
Published: 2007
Journal Articles

A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.

Free
Srdan Verstovsek, Animesh D. Pardanani, Neil P. Shah, Lubomir Sokol, Martha Wadleigh, D. Gary Gilliland, Alan F. List, Ayalew Tefferi, Hagop M. Kantarjian, Lynne A. Bui, Douglas O. Clary
Journal: Blood
Blood (2007) 110 (11): 553.
https://doi.org/10.1182/blood.V110.11.553.553
Published: 2007
Journal Articles

Regulated Expression of Activated Notch 1 during Embryonic Stem Cell Differentiation Preserves Multipotential Progenitors and Promotes Erythroid Cell Fate.

Free
Uma Ganapati, Ph.D., Lynne A. Bui, M.D., Maureen Lynch, Milana Dolezal, M.D., Hongying Tina Tan, M.D. Ph.D., Sven deVos, M.D., Ph.D., Judith C. Gasson, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4151.
https://doi.org/10.1182/blood.V104.11.4151.4151
Published: 2004